Position in BIIB
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$367,734
-$58,141 QoQ
Shares Held
1,702
-26.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#631
of 1,036 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Philip James Wealth Mangement, LLC holds $77,068,819 across 8 Drug Manufacturers - General names. BIIB ranks #8 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
173,727 | $22,323,919 | |
| 2 | JNJ |
Johnson & Johnson
|
81,906 | $20,801,666 | |
| 3 | NVO |
Novo Nordisk A S
|
269,741 | $12,931,383 | |
| 4 | PFE |
Pfizer Inc
|
443,426 | $10,677,698 | |
| 5 | LLY |
ELI LILLY & Co
|
4,241 | $5,086,783 | |
| 6 | AMGN |
Amgen Inc
|
8,948 | $3,240,249 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
12,976 | $1,639,387 | |
| 8 | BIIB |
Biogen Inc.
This page
|
1,702 | $367,734 |
All Filings in BIIB
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $367,734 | 1,702 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $425,875 | 2,323 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $409,704 | 2,328 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $300,611 | 2,146 | Shares | Sole | 2025-10-24 | |
| No filing history on record for this holder in this stock. | ||||||